Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Mobic (meloxicam) Tablets, 7.5 & 15 mg., Boehringer Ingleheim NDA 20-938/S7 4/28/03 Mobic (meloxicam) Tablets, 7.5 mg., Boehringer Ingleheim NDA 20-938 4/13/00 4/17/00 4/17/00 7/18/01 Mobic Indication: Relief of the signs and symptoms of Osteoarthritis. Mobic (meloxicam) Oral Suspension, Boehringer Ingelheim | Mobic (meloxicam) Tablets, Boehringer Ingelheim, Labeling Revision & New or Modified Indication | Mobic (meloxicam) Oral Suspension, Boehringer Ingelheim, Labeling Revision & New or Modified Indication | Meloxicam Tablets, Apotex Inc., Approval | Meloxicam Tablets, Genpharm Inc., Approval | Meloxicam Tablets, Caraco Pharma, Approval | Meloxicam Tablets, Breckenridge Pharma, Approval | Meloxicam Tablets, Zydus Pharma, Approval | Meloxicam Tablets, Mylan Pharma, Approval | Meloxicam Tablets, Roxane Labs, Approval | Meloxicam Tablets, Par Pharma, Approval | Meloxicam Tablets, Watson Labs, Approval | Meloxicam Tablets, CorePharma, Approval | Meloxicam Tablets, Glemark Pharma, Approval | Meloxicam Tablets, Teva Pharma, Approval | Meloxicam Tablets, Actavis Totowa, Approval | Meloxicam Tablets, Lupin Limited, Approval | Meloxicam Tablets, Mutual Pharma, Approval | Meloxicam Tablets, Dr. Reddy’s Labs, Approval | Meloxicam Tablets, Aurobindo Pharma, Approval | Meloxicam Tablets, Taro Pharma, Approval | Meloxicam Tablets, Carlsbad Technology, Approval | Meloxicam Tablets, Ranbaxy Labs, Approval | Meloxicam Tablets, Unichem Labs, Approval | Mobic (meloxicam) Tablets, Boehringer Ingelheim, Labeling Revision | Mobic (meloxicam) Oral Suspension, Boehringer Ingelheim, Labeling Revision | Meloxicam Tablets, Aurobindo Pharma, Labeling | Meloxicam Tablets, Caraco Pharma Labs, Labeling | Meloxicam Tablets, Teva Pharma, Labeling | Mobic (meloxicam) Oral Suspension, Boehringer Ingelheim Pharmaceuticals, Inc., Labeling Revision | Mobic (meloxicam) Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Labeling Revision | Meloxicam Tablets, Beijing Double-Crane Pharmaceutical Co., Ltd., Supplement ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com